Top

Pathology & Oncology Research

Published in:

01-03-2005 | Article

Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium

Authors: Sema Bircan, Arzu Ensari, Sibel Ozturk, Nural Erdogan, Ilkkan Dundar, Firat Ortac

Published in: Pathology & Oncology Research | Issue 1/2005

Title: Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium
Authors: Sema Bircan
Arzu Ensari
Sibel Ozturk
Nural Erdogan
Ilkkan Dundar
Firat Ortac
Publication date: 01-03-2005
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 1/2005
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/BF03032403

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2005

Gastrointestinal stromal tumors: A clinicopathologic and immunohistochemical study of 136 cases

Is quadrant biopsy sufficient in men likely to have advanced prostate cancer? Comparison with extended biopsy

Changes of cell adhesion and extracellular matrix (ECM) components in cervical intraepithelial neoplasia

Genomics of lung cancer may change diagnosis, prognosis and therapy

Familial cystic nephroma in two siblings with pleuropulmonary blastoma

Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue

Keynote webinar | Spotlight on antibody–drug conjugates in cancer